Professor of Pediatrics, University Iowa College of Medicine
Pediatric Pulmonology
Dr. Richard C. Ahrens, MD
|
|
Give Review
Richard C. Ahrens, MD practices Pediatric Pulmonology. He went to medical school at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54 in research and 62 in primary care medicine Doctor Richard C. Ahrens, MD is also published. He has 64 publications published. The lastest publication: "Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study...'
Publications
- Bioassay of salmeterol in children using methacholine challenge with impulse oscillometry.
- Efficacy response in CF patients treated with ivacaftor: Post-hoc analysis.
- CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.
- Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis.
- Intestinal CCL11 and Eosinophilic Inflammation Is Regulated by Myeloid Cell-Specific RelA/p65 in Mice.
- Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.
- Long-Term Intersession Variability for Single-Breath Diffusing Capacity.
- Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.
- Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.
- Standardization of the single-breath diffusing capacity in a multicenter clinical trial.
- The role of the MDI and DPI in pediatric patients: "Children are not just miniature adults".
- Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.
- Tobramycin as a pharmacologic tracer to compare airway deposition from nebulizers.
- A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis.
- Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis.
- Nonprescription racemic epinephrine for Asthma.
- The cold war against RSV.
- Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-depen...
- Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis.
- Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism.
- Adrenergic drugs for the treatment of Asthma.
- Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis.
- Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility.
- Disposable jet nebulizers. How reliable are they?
- Exercise-induced laryngomalacia.
- The delivery of therapeutic aerosols through endotracheal tubes.
- Evaluation of particle size distribution of salmeterol administered via metered-dose inhaler with and without valved holding chambers.
- Pharmacologic management of reversible obstructive airways disease.
- Tetany and renal Failure prior to chemotherapy in acute lymphocytic leukemia.
- Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in Systemic and oral antigen-induced anaphylaxis.
- A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic in...
- Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with Asthma.
- Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study...
- Oral prednisolone for viral wheeze in young children.
- Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis.
- Asthma prevalence and morbidity among rural Iowa schoolchildren.
- Albuterol: an adrenergic agent for use in the treatment of Asthma pharmacology, pharmacokinetics and clinical use.
- A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine.
- Chronic cough in childhood: approach to diagnosis and treatment.
- Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients.
- Clinical pharmacology of drugs used for Asthma.
- Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.
- Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting ??-adrenergic agonist.
- Extrapulmonary effects of maintenance therapy with theophylline and inhaled albuterol in patients with chronic Asthma.
- Bioequivalence of a generic slow-release theophylline tablet in children.
- Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic Asthma.
- Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important considerat...
- Response to nonprescription epinephrine inhaler during nocturnal Asthma.
- A bioassay for topical and Systemic effect of three inhaled corticosteroids.
- Therapeutic ratio of inhaled corticosteroids: fact or fiction?
- The effect of theophylline and beta 2 agonists on airway reactivity.
- The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis.
- Dose response of inhaled gallopamil (D600), a calcium channel blocker, in attenuating airway reactivity to methacholine and exercise.
- Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection.
- Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine.
- Levalbuterol and racemic albuterol: are there therapeutic differences?
- Comparison of the intensity and duration of effects of inhaled bitolterol and albuterol on airway caliber and airway responsiveness to histamine.
- Demonstration of in vivo bioequivalence of a generic albuterol metered-dose inhaler to Ventolin.
- Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with Asthma.
- Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
- Asthma stability after oral prednisone: a clinical model for comparing inhaled steroid potency.
- Response to inhaled albuterol during nocturnal Asthma.
- Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
Schools
Medical College of Wisconsin
St Louis
University Iowa
Conditions Treated
- Allergic Rhinitis
- Asthma
- Bronchiectasis
- Bronchopulmonary Dysplasia
- View All
Doctors Specialties
- Pediatric Pulmonology
Accepted Insurances
Education
-
University of Iowa Hospitals and Clinics -
St Louis University School of Medicine -
Medical College of Wisconsin
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417389735 |
| Last Name Of The Provider | AHRENS |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Miles M. Weinberger, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Timothy D. Starner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra B. Iannone, DO |
|
|
Dr. Anthony J. Fischer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christoph O. Randak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey J. Smith, MD |